Fig 3.
Description of clinical course and pertinent molecular and immunohistochemical findings for the three patient cases presented. (*) Treatment ongoing as of April 1, 2018.
Description of clinical course and pertinent molecular and immunohistochemical findings for the three patient cases presented. (*) Treatment ongoing as of April 1, 2018.